as 07-26-2024 4:00pm EST
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
Founded: | 1963 | Country: | United States |
Employees: | N/A | City: | WOONSOCKET |
Market Cap: | 72.8B | IPO Year: | N/A |
Target Price: | $76.10 | AVG Volume (30 days): | 8.4M |
Analyst Decision: | Buy | Number of Analysts: | 21 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 5.70 | EPS Growth: | 82.69 |
52 Week Low/High: | $52.77 - $83.25 | Next Earning Date: | 08-07-2024 |
Revenue: | $360,935,000,000 | Revenue Growth: | 9.07% |
Revenue Growth (this year): | 4.1% | Revenue Growth (next year): | 4.96% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
LUDWIG EDWARD J | CVS | Director | May 2 '24 | Buy | $53.88 | 1,000 | $53,879.00 | 21,630 | SEC Form 4 |
Mahoney Michael F | CVS | Director | May 2 '24 | Buy | $54.49 | 9,181 | $500,293.81 | 9,356 | SEC Form 4 |
LUDWIG EDWARD J | CVS | Director | Nov 3 '23 | Buy | $70.47 | 2,000 | $140,930.00 | 20,630 | SEC Form 4 |
CVS Breaking Stock News: Dive into CVS Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Retail Dive
2 days ago
The Wall Street Journal
2 days ago
Insider Monkey
2 days ago
Zacks
2 days ago
Simply Wall St.
2 days ago
Healthcare Dive
3 days ago
The Wall Street Journal
3 days ago
The information presented on this page, "CVS CVS Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.